Overview A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery Status: Recruiting Trial end date: 2023-06-30 Target enrollment: Participant gender: Summary The purpose of this study is to assess the safety and efficacy of K-321 in subjects after cataract surgery Phase: Phase 3 Details Lead Sponsor: Kowa Research Institute, Inc.